Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nehra

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Gastroenterology Clinics of North America|July 3, 1998
New clinical issues in celiac diseaseV Nehra
Mayo Clinic Proceedings|November 13, 2001
40-year-old man with anemia, chronic low back pain, and hypoalbuminemiaC O Zein, V Nehra
Nutrition (Burbank, Los Angeles County, Calif.)|May 1, 1995
Medium-chain triglycerides: a new frontierV Nehra, E A Mascioli
Drugs of Today (Barcelona, Spain : 1998)|November 10, 2017
Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in childrenS A Rizza, V Nehra, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|August 10, 2018
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adultsV Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|April 28, 2017
Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infectionV Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infectionV Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
BoceprevirS A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2016
Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infectionV Nehra, E M Tan, S A Rizza, et al.
Digestive Diseases and Sciences|November 21, 2001
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitisV Nehra, P Angulo, A L Buchman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Gastroenterology Clinics of North America|July 3, 1998
New clinical issues in celiac diseaseV Nehra
Mayo Clinic Proceedings|November 13, 2001
40-year-old man with anemia, chronic low back pain, and hypoalbuminemiaC O Zein, V Nehra
Nutrition (Burbank, Los Angeles County, Calif.)|May 1, 1995
Medium-chain triglycerides: a new frontierV Nehra, E A Mascioli
Drugs of Today (Barcelona, Spain : 1998)|November 10, 2017
Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in childrenS A Rizza, V Nehra, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|August 10, 2018
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adultsV Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|April 28, 2017
Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infectionV Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infectionV Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
BoceprevirS A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2016
Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infectionV Nehra, E M Tan, S A Rizza, et al.
Digestive Diseases and Sciences|November 21, 2001
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitisV Nehra, P Angulo, A L Buchman, et al.
Pageof 3